There were no cases of vaccination … influenza vaccine from exposure to room temperature, at least 224 people in Seoul, Busan, Jeonbuk and Jeollanam-do were vaccinated, and the number could increase.



[ad_1]

Entry 2020.09.25 21:34 | Revision 2020.09.25 22:28

As of day 25, it was confirmed that at least 224 people received the influenza (flu) vaccine, which was discontinued due to exposure to room temperature. The government said that the vaccines exposed to room temperature were not vaccinated on the 22nd.

The Korean Centers for Disease Control and Prevention (KCDC), which is investigating the poor circulation of the national flu vaccine, has received a total of 105 people from four regions, including Seoul, Busan, Jeonbuk and Jeonnam to the day before, as a result of the investigation in the briefing as a result of the interim control. It was confirmed that he had been vaccinated. Of these, 60 were vaccinated staff at a Jeonju hospital, Jeonbuk.

Jeong Eun-kyung, Head of Defense Response Headquarters (Disease Management Administration, right) and Kim Sang-bong, Head of Biopharmaceutical Bureau, Ministry of Food and Drug Safety, who attended the briefing on 25./Yonhap News

However, Jeonju announced separately that to date 179 Jeonju residents had been vaccinated against exposure to room temperature. According to announcements from the Jeonju and Korea Disease Administration, at least 224 people have been vaccinated against the problem in 4 provinces so far.

“The number of 179 people identified by Jeonju is the number that Jeonju has determined for itself,” said the Korean Disease Administration. “Because we are constantly investigating the hospitals where the vaccine was administered, the number can continually change.”

According to the Korea National Disease Service Agency, Jeonju Hospital was managed without distinction between state-supplied vaccines and private-sector-supplied vaccines, and for this reason, 60 out of 594 inoculated at the hospital received the vaccine suspected of being exposed to room temperature.

The Agency for Disease Control and Prevention is testing 750 samples from 600,000 to 750,000 people in five regions where the vaccine suspected of being exposed to room temperature was first given. The Agency for Disease Control and Prevention plans to expand the test if a suspicious amount of exposure at room temperature emerges from further investigation. The inspection period is expected to last about two weeks.

According to the Agency for Disease Control and Prevention, influenza vaccines suspected of being exposed at room temperature are kept in quality for a minimum of 14 days to a maximum of 6 months at 25 degrees Celsius in safety testing from the manufacturer itself. However, the expert advice meeting organized by the Korea Disease Administration and the Ministry of Food and Drug Safety said: “The possibility of quality change is small due to the nature of the flu vaccine that is supplied. in a sealed state, but it is necessary to examine whether the effectiveness of the vaccine degrades when exposed to room temperature. ”

Previously, the Agency for Disease Control and Prevention said the vaccine was not vaccinated when part of the vaccine was found to be exposed to room temperature. In a briefing on the morning of the 22nd, the Korean Centers for Disease Control and Prevention, Chung Eun-kyung, said in a briefing on the morning of the 22nd: “The government buys about 12.59 million people from through a procurement contract and supplies them to medical institutions by wholesalers. On the 22nd, they tried to obtain free vaccines, but the national vaccination business was temporarily suspended on the 21st as exposure to room temperature was confirmed during the delivery process of the vaccine.

[ad_2]